Persistent Barriers to Early Breast Cancer Detection in the United States

Commentators note that, despite a long-term decline in mortality, the U.S. health-care system continues to impede timely breast-cancer screening and diagnosis. A recent opinion piece by Sally C. Pipes, president and CEO of the Pacific Research Institute, highlights the administration’s new women’s-health initiative—led by former first lady Melania Trump—as a potential lever for change, emphasizing greater patient control, reduced administrative friction, and fewer restrictions on competition.

Newsweek

Researchers at the National Cancer Institute and the American Cancer Society reported that among Medicare beneficiaries, first-year oral prescription-drug costs average roughly $700 for localized breast cancer but rise to about $25,000 after metastasis. Corresponding cancer-attributable medical spending more than doubles, increasing from roughly $34,000 to over $73,000 once the disease spreads. The American Cancer Society attributes a 44 % drop in breast-cancer death rates since the 1989 peak to earlier diagnosis and improved treatment. Five-year survival rates remain high—about 90 % in the United States compared with 88 % in Canada, 87 % in France, and 86 % in the United Kingdom.

Newsweek

In 2023, 79.8 % of women aged 50-74 reported a mammogram within the prior two years, a figure that has scarcely changed since 2019. Roughly 10 % of screened women receive a callback for additional evaluation, and some abnormal mammograms have taken more than 70 days to resolve at certain imaging centers. Insurance pre-authorization requirements—such as Cigna’s precertification for high-tech imaging and UnitedHealthcare’s prior-authorization rules—add further hurdles. A national study estimated that 8.2 million women ages 45-84 live more than a 20-minute drive from the nearest mammography facility, while certificate-of-need laws in several states continue to limit the addition of imaging capacity.

Newsweek

The commentary urges that, once a suspicious finding emerges, approvals should be automatic and paperwork minimized. It also calls on states to eliminate certificate-of-need regulations that restrict diagnostic-imaging providers, arguing that increased competition would expand access and shorten travel times. As Breast Cancer Awareness Month approaches, the piece stresses that public reminders to screen, clearer symptom information, and streamlined follow-up processes are essential to capitalize on the proven medical and financial benefits of early detection.

Newsweek